Quality Risk Assessment for New Sterile Product Introduction
Objective: Evaluate and control risks before introducing a new sterile product to ensure patient safety, sterility assurance, product quality, and GMP compliance.
Key Risk Areas
- Product & Process
- Formulation compatibility
- Critical Quality Attributes (CQAs)
- Critical Process Parameters (CPPs)
- Aseptic processing requirements
- Terminal sterilization feasibility
- Facility & Utilities
- Cleanroom classification & zoning
- HVAC capacity and airflow pattern
- WFI/PW and clean steam capacity
- Compressed gases
- Environmental Monitoring (EM) capability
- Equipment
- Equipment suitability & capacity
- Product-contact material compatibility
- Cleaning & sterilization requirements
- Equipment qualification status
- Contamination Risks
- Microbial contamination
- Cross-contamination
- Particulate contamination
- Personnel/material movement
- Bioburden and endotoxin risks
- Sterility Assurance
- Sterilization/decontamination validation
- Media fill/APS requirements
- Container Closure Integrity (CCI)
- Hold-time studies
- Filter integrity testing, where applicable
- Cleaning & Validation
- Cleaning procedure and validation
- Product changeover risks
- Analytical method suitability
- Process validation requirements
- Personnel & Training
- Operator qualification
- Aseptic technique training
- Gowning qualification
- Training on new process/equipment
- Regulatory & Documentation
- GMP/regulatory requirements
- SOPs and batch documents
- Change Control
- Validation Master Plan impact
- Quality Risk Management (QRM/FMEA)
Risk Assessment Flow
New Product → Identify Hazards → Assess Risk → FMEA/Risk Matrix → Define Controls → Implement Controls → Qualification/Validation → QA Approval → Continued Monitoring
QA Focus:
“No new sterile product should be introduced until facility, process, equipment, utilities, contamination-control strategy, validation, and personnel-readiness risks are adequately assessed and controlled.”